MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$75,253K
Net Income
-$194,280K
Net Profit Margin
-258.17%
EPS
-$1.36
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
75,253
73,737
264,033
-26,266*
Research and development
198,223
173,253
177,203
163,953*
General and administrative
-
-
46,021
34,912*
Selling, general and administrative
47,123
41,744
-
-
Total operating expenses
245,346
214,997
223,224
198,865*
Operating (gain) income
-170,093
-141,260
40,809
-225,131*
Interest income
16,935
16,869
9,690
6,338*
Interest expense
24,562
23,846
22,505
20,329*
Loss on equity method investment
-2,470
-6,719
-
-
Gain on vie's sale of ipr&d assets
0
19,000
-
-
Other, net
1,285
-1,609
277
4,866*
Total other (expense) income
-8,812
3,695
-12,538
-9,125*
(gain) income before income tax expense (benefit) and noncontrolling interest
-178,905
-137,565
28,271
-234,257*
Income tax expense (benefit)
11
7
29
19,445*
Net (gain) income including noncontrolling interest
-178,916
-137,572
28,242
-253,702*
Net income (loss) attributable to noncontrolling interest, net of tax
15,364
-4,840
-2,569
40,735*
Net (loss) income attributable to arrowhead pharmaceuticals, inc
-194,280
-132,732
30,811
-294,437
Basic EPS
-1.36
-0.93
0.22
-2.285
Diluted EPS
-1.36
-0.93
0.22
-2.305
Basic Average Shares
143,378,000
142,417,000
137,039,000
128,872,000
Diluted Average Shares
143,378,000
142,417,000
140,706,000
127,751,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net (loss) income
attributable to arrowhead...
-$194,280K
(-10.86%↓ Y/Y)
Net (gain) income
including noncontrolling...
-$178,916K
(-0.15%↓ Y/Y)
Net income (loss)
attributable to...
$15,364K
(550.43%↑ Y/Y)
(gain) income before
income tax expense...
-$178,905K
(0.10%↑ Y/Y)
Income tax expense
(benefit)
$11K
(102.52%↑ Y/Y)
Operating (gain) income
-$170,093K
(-2.74%↓ Y/Y)
Total other (expense)
income
-$8,812K
(34.91%↑ Y/Y)
Revenue
$75,253K
(171.02%↑ Y/Y)
Interest income
$16,935K
(53.69%↑ Y/Y)
Other, net
$1,285K
(830.11%↑ Y/Y)
Total operating
expenses
$245,346K
(26.91%↑ Y/Y)
Interest expense
$24,562K
(0.74%↑ Y/Y)
Loss on equity method
investment
-$2,470K
Research and development
$198,223K
(22.08%↑ Y/Y)
Selling, general and
administrative
$47,123K
Buy us a coffee
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)